Description

PharmaQo Winstrol 50 delivers 50 mg Stanozolol per oral tablet, supplied in 60-tablet packs for research purposes. Stanozolol is under investigation for its anabolic effects, nitrogen retention capacity, lean tissue preservation, and potential use in bone and metabolic studies.

Its non-aromatizing nature and high anabolic-to-androgenic ratio make it a common candidate for research exploring tissue-building with minimized androgenic side effects.

Product Details:
Active Ingredient:

• Stanozolol (Winstrol)

Concentration: 50 mg per tablet

Form: Oral tablets

Packaging: 60 tablets per pack

Pharmacokinetics:
Stanozolol has an oral half-life of ~9 hours, requiring once or twice daily dosing in research protocols.

Usage Recommendations:

• Indications (Research Context): Investigational use in anabolic and nitrogen retention models, lean mass preservation, metabolic research (not approved for human use)

• Typical Dosage (Research Use): 25–100 mg per day, depending on study parameters

• Monitoring: Liver enzymes, lipid levels, cardiovascular status, androgenic markers

• Cycle/Duration: 4–8 weeks, as per research design

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always adhere to local research laws and ethical guidelines.